NCT01704924

Brief Summary

This study aims to assess the quality of wound healing in abdominal scars with and without the Prevena Incision Management System. The hypothesis is that Prevena will lead to improved wound healing with less swelling, bruising, and inflammation, as well as less potential for infection, seroma, and dehiscence.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

October 9, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 12, 2012

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

January 19, 2018

Status Verified

January 1, 2018

Enrollment Period

4.2 years

First QC Date

October 9, 2012

Last Update Submit

January 17, 2018

Conditions

Keywords

Prevenanegative pressure wound therapyIncisional wound vac

Outcome Measures

Primary Outcomes (1)

  • Scarring

    Assess quality of scar: hypertrophy, hyperpigmentation, etc

    0-6 months

Study Arms (2)

Prevena

ACTIVE COMPARATOR

Incision with prevena device overlying

Device: Prevena

Standard of Care dressing

ACTIVE COMPARATOR

Prevena device is not used

Procedure: Standard of Care Dressing

Interventions

PrevenaDEVICE

Device will be applied at end of procedure over closed incision

Prevena

Dressing applied as Standard of Care

Standard of Care dressing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • abdominal procedure with incision \>20cm
  • must be \>18 years of age

You may not qualify if:

  • \<18 years of age
  • history of allergy or reaction to adhesives
  • pregnant or anticipated pregnancy within 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California at Irvine

Orange, California, 92868, United States

Location

Related Publications (2)

  • Pachowsky M, Gusinde J, Klein A, Lehrl S, Schulz-Drost S, Schlechtweg P, Pauser J, Gelse K, Brem MH. Negative pressure wound therapy to prevent seromas and treat surgical incisions after total hip arthroplasty. Int Orthop. 2012 Apr;36(4):719-22. doi: 10.1007/s00264-011-1321-8. Epub 2011 Jul 15.

    PMID: 21761149BACKGROUND
  • Stannard JP, Volgas DA, McGwin G 3rd, Stewart RL, Obremskey W, Moore T, Anglen JO. Incisional negative pressure wound therapy after high-risk lower extremity fractures. J Orthop Trauma. 2012 Jan;26(1):37-42. doi: 10.1097/BOT.0b013e318216b1e5.

    PMID: 21804414BACKGROUND

Related Links

MeSH Terms

Conditions

Cicatrix

Condition Hierarchy (Ancestors)

FibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gregory Evans, MD

    The University of California Irvine

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 9, 2012

First Posted

October 12, 2012

Study Start

October 1, 2012

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

January 19, 2018

Record last verified: 2018-01

Locations